Reassessing cognitive impairment prevalence in 5-FU chemotherapy: A critical methodological perspective
dc.contributor.author | Whittaker, A.L. | |
dc.contributor.author | Semendric, I. | |
dc.date.issued | 2025 | |
dc.description | Letter to Editor | |
dc.description.statementofresponsibility | Alexandra L Whittaker, Ines Semendric | |
dc.identifier.citation | Cancer Research, Statistics, and Treatment, 2025; 8(1):83-84 | |
dc.identifier.doi | 10.4103/crst.crst_31_25 | |
dc.identifier.issn | 2590-3233 | |
dc.identifier.issn | 2590-3225 | |
dc.identifier.orcid | Whittaker, A.L. [0000-0001-9011-8296] | |
dc.identifier.orcid | Semendric, I. [0000-0002-7099-929X] | |
dc.identifier.uri | https://hdl.handle.net/2440/144782 | |
dc.language.iso | en | |
dc.publisher | Wolters Kluwer Medknow Publications | |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1140072 | |
dc.rights | © 2025 Cancer Research, Statistics, and Treatment | Published by Wolters Kluwer - Medknow. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. | |
dc.source.uri | https://doi.org/10.4103/crst.crst_31_25 | |
dc.title | Reassessing cognitive impairment prevalence in 5-FU chemotherapy: A critical methodological perspective | |
dc.type | Journal article | |
pubs.publication-status | Published |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- hdl_144782.pdf
- Size:
- 300.58 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version